Trial Profile
A open label, pharmacokinetic trial of once daily extended release topiramate in elderly subjetcs
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Supernus Pharmaceuticals
- 06 Dec 2015 New trial record